One of the most active segments of additive manufacturing, bio-printing is used from dental to surgical applications. This segment is expected to become 1.8 billion dollars market until 2021.
Presenting 3D printing advantages in organ, tissue and dental applications, bio-printing is among the most followed topics of the sector. Expected to anble many important medical findings, this sector is growing rapidly. According to the market researches, bioprinting will reach almost 1.8 billion dollars of market share.
Presently, global 3D healthcare printing market is driven by the advancement in technology, increase in the percentage of aging population as old age is considered as the high risk factor for the development of various disorders, improvement in the healthcare infrastructure, and increase in the investment in research and development sector.
Technological advances in this dynamic industry are ever ongoing applications of additive manufacturing in healthcare are expanding. However, lack of skilled professional act as a major barrier for 3D healthcare printing global market.
Emerging medical applications of 3D bioprinting such as toxicity testing, drug discovery, tissue engineering and consumer product testing are expected to further drive the market growth positively. Increasing R&D expenditure is anticipated to be high impact rendering driver for the industry. 3D bioprinting advances in tissue engineering and allows developments to be done using biomaterials which have better biocompatibility. Moreover, rising geriatric population is expected to assist the market growth, as this demographic is highly susceptible to age related organ deformities.